tirzepatide cardiovascular outcomes study compared with semaglutide and 10-year disease risk reduction in obesity: post-hoc analysis of the SURMOUNT-5 trial Tirzepatide and Cardiovascular Outcomes: A

We did not obtain informed consent from individual participants involved in our study because we used anonymized data compiled from EMRs

This comparative study evaluates the incidence of heartburn across different GLP-1 receptor agonists, providing insights into semaglutides relative gastrointestinal safety profile

However, limited data in preclinical species have demonstrated that triple receptor agonists reduce calorie intake

Comparative Glycemic and Anthropometric Outcomes Baseline HbA1c levels were similar across groups

It depends on your age, baseline skin elasticity, speed of loss, and where the weight comes off

Research looks at mechanisms such as reducing oxidative stress, modulating growth factors, and impacting extracellular matrix and how all of these connect to gamete quality, implantation, and tissue repair after injury